ArticleFrontiers in medicine2026
A combined score based on anterior chest wall CT attenuation to aid recognition of SAPHO syndrome: a training-validation study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate whether quantitative anterior chest wall CT attenuation can aid recognition of SAPHO syndrome, to develop a simple combined score, and to evaluate its discriminatory performance in a validation set. Methods: We retrospectively enrolled 260 patients with SAPHO syndrome and 260 age- and sex-matched healthy controls. CT attenuation values were measured at five sites: the left and right clavicular heads, the left and right upper manubrium, and the sternal angle, and were normalized to the CT attenuation of an internal reference vertebra. Using stratified random sampling (7:3), the total sample was divided into a training set (364 cases: 182 SAPHO and 182 controls) and a validation set (156 cases: 78 SAPHO and 78 controls). In the training set, ROC analysis was used to compare individual ratios and additive combinations, establish the combined score, and determine the optimal cutoff. The fixed cutoff was then applied to the validation set. In addition, a subgroup analysis was performed in SAPHO patients without obvious anterior chest wall CT morphological changes. Results: In the training set, the combined score achieved an AUC of 0.980 (95% CI: 0.969-0.991). At the optimal cutoff of >5.412, sensitivity and specificity were both 93.41%. In the validation set, using the same cutoff, the AUC was 0.976 (95% CI: 0.958-0.993), with a sensitivity of 92.3% and a specificity of 84.6%. Among 96 SAPHO patients without obvious anterior chest wall CT morphological changes, 81 (84.4%) had combined scores above the fixed cutoff; the AUC for distinguishing this subgroup from healthy controls was 0.956 (95% CI: 0.935-0.974). Conclusion: The combined score based on multi-site anterior chest wall CT attenuation demonstrated high discriminatory ability between SAPHO patients and healthy controls and showed consistent performance in the internal validation set. In patients without obvious anterior chest wall CT morphological changes, the score provided additional quantitative imaging information and may serve as an objective complement to conventional morphological assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.